About

Company description

Grøntvedt Biotech is a Norwegian Biotech company which derives  Omega-11 (Cetoleic acid) & Omega-3 from Norwegian Pelagic fish. Grøntvedt Biotech is part of Grøntvedt Group which have worked with Norwegian Pelagic fish since 1830 and have its full operation at Uthaug in Norway wherre the full production is taking place from fresh fish into marine products.

Omega-11 (Cetoleic acid) have proven to boost the bodies own production of EPA/DHA and new science have revealed severeal health benefits for hearth health, brain health and skin health. Grøntvedt Biotechs product CETO3® - Omega-11 have high Omega-11 (Cetoleic acid) content. There is several ongoing clinical trials on CETO3® - Omega-11 and its health benefits.

Immediate processing, from fresh fish to oil in as little as 30 minutes, secures unique sensory qualities. Product can be taken as a liquide or in  capsules,

Quick facts

Sales markets Asia; Australia; Central/South America; Eastern Europe; North America; Western Europe
Primary business activity Manufacturer: Ingredients / Additives
Affiliated categories: Essential Oils |Fish /Marine ingredients |Food Supplements / Nutraceuticals More

Upcoming events

19 may 2025

Vitafoods Europe 2025

19 - 21 May 2025 Barcelona, Spain Visit us at stand 3L256 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

14 may 2024

Vitafoods Europe 2024

14 - 16 May 2024 - Geneva, Switzerland We were at stand D64 See our Exhibitor Profile   See full Exhibitor List
GRONTVEDT BIOTECH

Contact information

Address

Email

Telephone

Website

View all contact information